covid-19 virus’s weekly COVID-19 news round-up

pharmafile | March 17, 2021 | News story | Research and Development COVID-19, covid-19 roundup, news roundup 

The past week has seen a mix of good and bad COVID-19 news; the Oxford-AstraZeneca vaccine rollout has halted throughout Europe due to blood-clotting fears, while Johnson & Johnson’s one-dose vaccine has been approved by the European Commission, and Eli Lilly’s treatment showed an efficacy of 87% in a Phase III trial.

1. AstraZeneca vaccine suspended in 11 European countries – Published 16/03/2021

Blood clot fears have caused 11 European countries to suspend the use of the Oxford-AstraZeneca vaccine.

2. Netherlands suspends AstraZeneca vaccine despite safety assurances – Published 15/03/21

The Netherlands has become the latest country to suspend the use of the Oxford-AstraZeneca vaccine amid concerns it may cause blood clotting, cancelling 43,000 vaccination appointments.

3. J&J’s one-shot COVID-19 vaccine approved by European Commission – Published 12/03/21

The European Commission has granted Johnson and Johnson’s single-shot COVID-19 vaccine Conditional Marketing Authorisation (CMA), it was announced on Thursday.

4. Novavax announces vaccine’s high efficacy against original and variant COVID-19 strains – Published – 12/03/21

Novavax has announced final efficacy of 96.4% against mild, moderate, and severe disease caused by the original COVID-19 strain in a pivotal UK Phase III trial of its vaccine NVX–CoV2373.

5. Eli Lilly’s COVID-19 treatment combination 87% effective in Phase III trial – Published 11/03/21

Eli Lilly has shown positive results in its Phase III combination drug trial, which reduced hospitalisations and deaths related to COVID-19.

Related Content

FDA approves first oral antiviral to treat adult patients with COVID-19

The US Food and Drug Administration (FDA) has announced that it has approved the oral …


Moderna and Pfizer COVID-19 vaccine protection declines over time

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on …

Sanofi complete acquisition of mRNA company Translate Bio

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal …

Latest content